Ophthalmology News

CHICAGO — Collaborations and consolidations within the eye care space will be potentially disruptive over the next 5 years, according to a market expert at Eyecelerator@AAO.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Greg Kunst of Aurion Biotech provides an update on the company’s cell therapy for corneal endothelial disease.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Richard Small, CEO of Neurotech Pharmaceuticals, provides a company update ahead of the American Academy of Ophthalmology Meeting.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Anthony Wallace of Bausch + Lomb provides an update on the latest happenings at the company.

Glaukos announced that Epioxa, its next-generation corneal cross-linking iLink therapy for the treatment of keratoconus, demonstrated statistically significant improvement from baseline vs. placebo in maximum corneal curvature at 12 months.

The Light Adjustable Lens offers a level of vision customization that benefits both patients and surgeons, according to a presentation at Real World Ophthalmology.

In our prior blog post, we discussed the frequent need to separate, from a legal and financial perspective, the real property from the practice in order to consummate a practice transaction with a private equity buyer.

CARLSBAD, Calif. — Patients with uveal melanoma who had Medicaid or no insurance were less likely to receive brachytherapy and more likely to be diagnosed at later stages, according to a study presented here.

Heidelberg Engineering obtained FDA clearance of its Spectralis Flex Module imaging platform, according to a press release.